Visit COVID-19 resources

[Skip to Content]

commissioning

Useful resources help open up the complex world of commissioning

Useful resources relating to the often highly complex world of commissioning – something that we know can be baffling at the best of times, including for those on the front line of the NHS. Informal feedback from colleagues at fellow medical royal colleges suggests that non-physician health professionals would find these resources really useful too. The

Lay Advisory Group comments on CCG embargo on eye treatments

The Lay Advisory Group of The Royal College of Ophthalmologists (RCOphth) advises the College on lay opinion concerning availability of treatments and the handling of patients. We have been informed that some CCGs are placing an embargo on several eye treatments and procedures from now until the end of the financial year. On the list

RCOphth concerned at the continued restriction of second eye cataract surgery by CCGs

The Royal College of Ophthalmologists is concerned to hear that there continues to be a restriction of second eye cataract surgery by some CCGs. The RCOphth stresses that the decision to perform second eye cataract surgery should be based entirely on clinical need. A report by the Scottish Health Technologies Group (Healthcare Improvement Scotland) identified evidence

Community Ophthalmology Framework Published

Eye conditions such as age-related macular degeneration (AMD) and glaucoma will increase as the population ages. The number of patients receiving treatments for AMD in the Hospital Eye Service is already nearing capacity and those patients with glaucoma require life-long follow up. This means that the current service model is becoming unsustainable. To tackle this

NHS Clinical Commissioners co-ordinate support from CCGs to review use of Avastin to treat wet AMD

College Statement In response to the public letters sent by the NHS Clinical Commissioners to Secretary of State for Health, cc. Chair of NICE; Simon Stevens at NHS England; and the Chair of the GMC and signed by the Clinical Chair / Lead Clinician of 120 CCGs regarding the use of Avastin to treat wet AMD. The Royal